Literature DB >> 10506708

Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone: analysis of the MRC AML 10 trial.

M Watson1, K Wheatley, G A Harrison, R Zittoun, R G Gray, A H Goldstone, A K Burnett.   

Abstract

BACKGROUND: Data relating to the impact of bone marrow transplantation (BMT) on sexual functioning are equivocal; some studies have shown no major impact whereas others demonstrate a significant adverse effect on sexual health in patients treated with BMT. Further clarification is required to facilitate treatment choices and follow-up management of patients.
METHODS: A cross-sectional study of sexual health and infertility was conducted in 479 patients with acute myeloid leukemia (AML) in first complete remission (CR) who were entered into the UK MRC AML 10 trial comparing allogeneic BMT (Allo-BMT), autologous BMT (A-BMT), and intensive consolidation chemotherapy (CCT). Assessment was made by patient questionnaire via the treating centers for completion and returned directly to the coordinating center.
RESULTS: Both Allo-BMT and A-BMT were observed to have severe, highly significant adverse effects on the patients' sexual health. Significantly more BMT patients than CCT patients reported a decrease in interest in sex (48% vs. 24%), sexual activity (53% vs. 35%), pleasure from sex (36% vs. 18%), and ability to have sex (38% vs. 18%) (P < 0.001 in each case). Hormonal disorders and infertility also were more common in BMT patients than in CCT patients. These differences were more apparent in women and remained after adjustment for age.
CONCLUSIONS: These results indicate a need to consider quality of life parameters when reviewing treatment options and to instigate effective proactive management strategies for dealing with sexual health problems in leukemia survivors. Copyright 1999 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10506708     DOI: 10.1002/(sici)1097-0142(19991001)86:7<1231::aid-cncr18>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  28 in total

1.  Who should be transplanted in first remission of acute myeloid leukaemia?

Authors:  Alan K Burnett; Robert K Hills
Journal:  Curr Treat Options Oncol       Date:  2011-12

Review 2.  Fertility considerations in young women with hematological malignancies.

Authors:  Pascale Jadoul; S Samuel Kim
Journal:  J Assist Reprod Genet       Date:  2012-05-22       Impact factor: 3.412

Review 3.  Clinical guide to fertility preservation in hematopoietic cell transplant recipients.

Authors:  S Joshi; B N Savani; E J Chow; M H Gilleece; J Halter; D A Jacobsohn; J Pidala; G P Quinn; J-Y Cahn; A A Jakubowski; N R Kamani; H M Lazarus; J D Rizzo; H C Schouten; G Socie; P Stratton; M L Sorror; A B Warwick; J R Wingard; A W Loren; N S Majhail
Journal:  Bone Marrow Transplant       Date:  2014-01-13       Impact factor: 5.483

4.  Pilot study of a multimodal intervention to enhance sexual function in survivors of hematopoietic stem cell transplantation.

Authors:  Areej El-Jawahri; Sarah R Fishman; Julie Vanderklish; Don S Dizon; Nicole Pensak; Lara Traeger; Joseph A Greer; Elyse R Park; Netana Markovitz; Lauren Waldman; Chrisa Hunnewell; Meredith Saylor; Jessica Driscoll; Zhigang Li; Thomas R Spitzer; Steven McAfee; Yi-Bin Chen; Jennifer S Temel
Journal:  Cancer       Date:  2018-03-14       Impact factor: 6.860

5.  Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Crystal S Denlinger; Tara Sanft; K Scott Baker; Shrujal Baxi; Gregory Broderick; Wendy Demark-Wahnefried; Debra L Friedman; Mindy Goldman; Melissa Hudson; Nazanin Khakpour; Allison King; Divya Koura; Elizabeth Kvale; Robin M Lally; Terry S Langbaum; Michelle Melisko; Jose G Montoya; Kathi Mooney; Javid J Moslehi; Tracey O'Connor; Linda Overholser; Electra D Paskett; Jeffrey Peppercorn; M Alma Rodriguez; Kathryn J Ruddy; Paula Silverman; Sophia Smith; Karen L Syrjala; Amye Tevaarwerk; Susan G Urba; Mark T Wakabayashi; Phyllis Zee; Deborah A Freedman-Cass; Nicole R McMillian
Journal:  J Natl Compr Canc Netw       Date:  2017-09       Impact factor: 11.908

6.  Survivorship: sexual dysfunction (female), version 1.2013.

Authors:  Crystal S Denlinger; Robert W Carlson; Madhuri Are; K Scott Baker; Elizabeth Davis; Stephen B Edge; Debra L Friedman; Mindy Goldman; Lee Jones; Allison King; Elizabeth Kvale; Terry S Langbaum; Jennifer A Ligibel; Mary S McCabe; Kevin T McVary; Michelle Melisko; Jose G Montoya; Kathi Mooney; Mary Ann Morgan; Tracey O'Connor; Electra D Paskett; Muhammad Raza; Karen L Syrjala; Susan G Urba; Mark T Wakabayashi; Phyllis Zee; Nicole McMillian; Deborah Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2014-02       Impact factor: 11.908

7.  Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years.

Authors:  Karen L Syrjala; Brenda F Kurland; Janet R Abrams; Jean E Sanders; Julia R Heiman
Journal:  Blood       Date:  2007-09-18       Impact factor: 22.113

Review 8.  Current approach to fertility preservation by embryo cryopreservation.

Authors:  Giuliano Bedoschi; Kutluk Oktay
Journal:  Fertil Steril       Date:  2013-03-25       Impact factor: 7.329

9.  Talking about women's sexual health after cancer: Why is it so hard to move the needle?

Authors:  Jennifer Barsky Reese; Sharon L Bober; Mary B Daly
Journal:  Cancer       Date:  2017-11-08       Impact factor: 6.860

10.  Sexual function in long-term male lymphoma survivors after high-dose therapy with autologous stem-cell transplantation.

Authors:  Hanne Skjerven Bersvendsen; Hege Sagstuen Haugnes; Alv A Dahl; Unn-Merete Fagerli; Øystein Fluge; Harald Holte; Mette Seland; Tom Wilsgaard; Knut Bjøro Smeland; Cecilie Essholt Kiserud
Journal:  Bone Marrow Transplant       Date:  2019-11-19       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.